全文获取类型
收费全文 | 931715篇 |
免费 | 67542篇 |
国内免费 | 1351篇 |
专业分类
耳鼻咽喉 | 12984篇 |
儿科学 | 24366篇 |
妇产科学 | 23234篇 |
基础医学 | 132978篇 |
口腔科学 | 28356篇 |
临床医学 | 80605篇 |
内科学 | 183512篇 |
皮肤病学 | 19242篇 |
神经病学 | 72298篇 |
特种医学 | 36828篇 |
外国民族医学 | 79篇 |
外科学 | 152312篇 |
综合类 | 18047篇 |
现状与发展 | 1篇 |
一般理论 | 234篇 |
预防医学 | 61761篇 |
眼科学 | 21317篇 |
药学 | 72563篇 |
3篇 | |
中国医学 | 2163篇 |
肿瘤学 | 57725篇 |
出版年
2018年 | 8982篇 |
2017年 | 7040篇 |
2016年 | 7771篇 |
2015年 | 8888篇 |
2014年 | 12004篇 |
2013年 | 17529篇 |
2012年 | 24141篇 |
2011年 | 25092篇 |
2010年 | 14825篇 |
2009年 | 14298篇 |
2008年 | 24648篇 |
2007年 | 25752篇 |
2006年 | 26539篇 |
2005年 | 25489篇 |
2004年 | 24614篇 |
2003年 | 23637篇 |
2002年 | 23210篇 |
2001年 | 54757篇 |
2000年 | 56576篇 |
1999年 | 46975篇 |
1998年 | 10743篇 |
1997年 | 9480篇 |
1996年 | 9609篇 |
1995年 | 8932篇 |
1994年 | 8286篇 |
1993年 | 7597篇 |
1992年 | 35505篇 |
1991年 | 33931篇 |
1990年 | 32743篇 |
1989年 | 31884篇 |
1988年 | 29005篇 |
1987年 | 28261篇 |
1986年 | 26297篇 |
1985年 | 25151篇 |
1984年 | 17845篇 |
1983年 | 15148篇 |
1982年 | 7798篇 |
1981年 | 6774篇 |
1979年 | 15793篇 |
1978年 | 10600篇 |
1977年 | 9059篇 |
1976年 | 7874篇 |
1975年 | 8632篇 |
1974年 | 10469篇 |
1973年 | 9861篇 |
1972年 | 9359篇 |
1971年 | 8856篇 |
1970年 | 8428篇 |
1969年 | 7927篇 |
1968年 | 7203篇 |
排序方式: 共有10000条查询结果,搜索用时 250 毫秒
991.
Mohammed E Abushaiqa Frank K Zaran David S Bach Richard T Smolarek Margo S Farber 《American journal of health-system pharmacy》2007,64(11):1170-1173
PURPOSE: Educational interventions to reduce the use of abbreviations and dosage designations that were deemed unsafe at a level 1 trauma center are described. SUMMARY: Strategies to reduce the use of unsafe abbreviations at Detroit Receiving Hospital were studied. Six abbreviations and dosage designations were deemed as unsafe by the site's medication-use and patient medical safety committees: (1) U for units, (2) microg for microgram, (3) TIW for three times a week, (4) the degree symbol for hour, (5) trailing zeros after a decimal point, and (6) the lack of leading zeros before a decimal point. Data on abbreviation use was collected starting in September 2003 by examining copies of patients' order sheets, which are sent from nursing units to the pharmacy for processing. Data were collected during three 24-hour periods each month, with 7-10 days between each period. A data collection sheet was developed to assist in documenting the number of opportunities for each unsafe abbreviation and the actual incidence of each. Educational strategies were developed and implemented starting in October 2003 to decrease the use of the unsafe abbreviations. These strategies included inservice education programs for the medical, pharmacy, and nursing staffs; laminated pocket cards; patient chart dividers; stickers; and interventions by pharmacists and nurses during medication prescribing. During the eight-month evaluation period, 20,160 orders were reviewed, representing 27,663 opportunities to use a designated unsafe abbreviation. Educational interventions successfully reduced the overall incidence of unsafe abbreviations from 19.69% to 3.31%. CONCLUSION: Educational interventions markedly reduced the use of unsafe abbreviations in medication orders over an eight-month evaluation period. 相似文献
992.
ImmunoCyt/uCyt is a fluorescent test combining three monoclonal antibodies. In this study, it has been tested as a complement to cytology in the detection of urothelial carcinoma in urine. It has been performed simultaneously with standard cytology and cystoscopy on 870 urine analyses from one hospital. In 136 cases, one or more bladder tumors were found. Overall sensitivity of cytology, ImmunoCyt/uCyt and combined analyses reached 29, 74 and 84%, respectively, and overall specificity was 98, 62 and 61%. The negative predictive value of cytology, ImmunoCyt/uCyt and both analyses was 88, 93 and 95%, respectively, and the positive predictive value was 70, 26 and 29%. The sensitivity of cytology for low malignant potential neoplasms, low- and high-grade papillary carcinomas was 6, 18 and 53%, while it reached 71, 79 and 93% when combined with ImmunoCyt/uCyt. The sensitivity of cytology for stages Ta, T1, T2 and over and Tis tumors was 12, 67, 47 and 50%, while it reached 78, 83, 79 and 100% when combined with ImmunoCyt/uCyt. In the absence of tumor on cystoscopy but with positive ImmunoCyt/uCyt, 18% of patients developed a tumor, 2-6 months later. Of the 109 cases diagnosed as suspicious for malignancy by cytology, a tumor was present in 30 cases and ImmunoCyt/uCyt was positive in 22 (73%) of them. In conclusion, ImmunoCyt/uCyt may be used to postpone cystoscopies in patients followed for bladder cancer and may help to save cytologist and pathologist screening time. 相似文献
993.
994.
Practical management of patients with non-small-cell lung cancer treated with gefitinib. 总被引:7,自引:0,他引:7
Neelam T Shah Mark G Kris William Pao Leslie B Tyson Barbara M Pizzo Murk-Hein Heinemann Leah Ben-Porat Dana L Sachs Robert T Heelan Vincent A Miller 《Journal of clinical oncology》2005,23(1):165-174
PURPOSE: The use of gefitinib, the first drug approved to inhibit the epidermal growth factor receptor tyrosine kinase, is indicated in patients with non-small-cell lung cancer with tumors progressive after chemotherapy. The unique mechanism of action of this agent leads to distinctive patterns of response and toxicity in persons with lung cancer. Many of the principles of management relevant to gefitinib are distinct from those with conventional cytotoxic drugs. To meet this need, we present practical guidelines on the use of gefitinib in patients with non-small-cell lung cancer. METHODS: This article reviews gefitinib's indications, dosing, response phenomena, and patterns of relapse in individuals with radiographic response. RESULTS: We present our recommendations for the management of rash and diarrhea caused by this agent. CONCLUSION: This information can guide practitioners and help them inform their patients about what to expect when they receive gefitinib. 相似文献
995.
Gerard J Molloy Derek W Johnston Chuan Gao Miles D Witham Joan M Gray Ishbel S Argo Allan D Struthers Marion E T McMurdo 《European journal of cardiovascular prevention and rehabilitation》2006,13(3):381-387
BACKGROUND: The impact of exercise programmes for heart failure on those close to the patient is largely unknown. We examined the effect of a hospital and home-based exercise intervention on burden, anxiety and depression of informal caregivers. DESIGN: The study was a randomized, controlled trial. Heart failure patients were randomized to a seated 12-week hospital-based exercise programme. Caregiver measures were gathered at baseline, 3 months later and 6 months following baseline. METHODS: Sixty caregivers (mean age 63.4 years, 65% female) of heart failure patients (n = 82, mean age 80.5 years, 44% female) participating in a trial of an exercise intervention were recruited. Caregiver burden, anxiety and depression were assessed. RESULTS: There were no differences in caregiver burden, depression or anxiety between the two groups of caregivers at baseline (caregiver burden, patient control 33.1 versus patient exercise 34.1; anxiety 4.1 versus 5.5; depression 2.8 versus 3.8). At 3 months there were no differences between caregivers in the two groups on outcomes. At 6-month follow-up caregivers of heart failure patients in the exercise group had burden scores that were significantly worse than the control group. There were no differences between the carers of exercise and control groups in anxiety and depression. Levels of anxiety and depression in the entire carer sample were marginally higher than reference values in a healthy non-clinical sample. CONCLUSION: The present exercise interventions for frail older patients did not benefit caregivers and was associated with an increase in caregiver burden. We suggest that future exercise interventions for heart failure patients should actively incorporate informal caregivers into research designs. 相似文献
996.
997.
998.
999.
1000.